Novonesis Flags Sales Growth in Q4, Affirms FY26 Guidance

MT Newswires · 2d ago
03:27 AM EST, 11/05/2026 (MT Newswires) -- Novonesis (NSIS-B.CO) provided a sales growth outlook for the fourth quarter and maintained its guidance for the full year. The biotechnology company expects organic sales growth in the high single digits for the fourth quarter, it said Thursday. For 2026, it still expects organic sales growth of 7% to 8%, including a close to 1 percentage point negative effect from exiting certain countries.